Abiologics
Abiologics provides programmable biologics designed to improve stability and tissue access. Its Synteins are engineered from non-natural blocks such as D-amino acids to boost protease resistance and lower immunogenicity. The company pairs generative AI with high-throughput chemical protein synthesis to design and make these molecules. This B2B biotech platform partners with pharmaceutical and biotech companies to advance novel biologics. Abiologics operates in a growing synthetic biology and therapeutics space, aiming to scale discovery and development.
Abiologics
Abiologics provides programmable biologics designed to improve stability and tissue access. Its Synteins are engineered from non-natural blocks such as D-amino acids to boost protease resistance and lower immunogenicity. The company pairs generative AI with high-throughput chemical protein synthesis to design and make these molecules. This B2B biotech platform partners with pharmaceutical and biotech companies to advance novel biologics. Abiologics operates in a growing synthetic biology and therapeutics space, aiming to scale discovery and development.